Early economic evaluation of chelation therapy in kidney transplant recipients with high-normal lead.
<h4>Background</h4>Kidney transplant recipients (KTR) with high-normal lead have a higher risk of graft failure (GF). Clinically, chelation therapy using meso-2,3-dimercaptosuccinic acid (DMSA) removes lead. Despite the proposal that chelation therapy can prevent GF through lead removal,...
Saved in:
| Main Authors: | Jiasi Hao, Behrooz Z Alizadeh, Maarten J Postma, Daan J Touw, Stephan J L Bakker, Lisa A de Jong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319022 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Exercise or Combined Exercise and Diet Intervention on Sleep and Fatigue in Kidney Transplant Recipients
by: Tim J. Knobbe, et al.
Published: (2025-07-01) -
Plasma Versus Whole Blood Tacrolimus Concentrations and Health-Related Quality of Life in Kidney Transplant Recipients
by: Svea Nolte, et al.
Published: (2025-04-01) -
Insights Into Health-Related Quality of Life of Kidney Transplant Recipients: A Narrative Review of Associated Factors
by: Tim J. Knobbe, et al.
Published: (2025-05-01) -
WCN24-1671 THE METABOLIC VULNERABILITY INDEX, REFLECTING MALNUTRITION AND INFLAMMATION, PREDICTS MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS
by: Sebastián Fuenzalida, et al.
Published: (2024-04-01) -
The gut microbiome and metabolome in kidney transplant recipients with normal and moderately decreased kidney function
by: Yang Lan, et al.
Published: (2023-12-01)